Kulkarni Samarth's Form 4 filing
CRISPR Therapeutics AG (CRSP) · filed Apr 17, 2024
- Accession no.
- 0000950170-24-045196
- Filed
- Apr 17, 2024
- Trade date
- Apr 15, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.17M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kulkarni SamarthCIK 0001682019 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | Common Shares | MOption exerciseAcquired | +19,582 | $19.12 | +$374,407.84 | 227,704 | Direct | |
| Apr 15, 2024 | Common Shares | SSaleDisposed | −18,378 | $59.88 | −$1,100,474.64 | 209,326 | Direct | |
| Apr 15, 2024 | Common Shares | SSaleDisposed | −1,204 | $60.40 | −$72,721.6 | 208,122 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | Common Shares | MOption exerciseDisposed | −19,582 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.